Pet medications
Search documents
Is Chewy Inc.’s (CHWY) AI Upside Enough to Justify Further Gains?
Yahoo Finance· 2026-01-23 09:16
Chewy, Inc. (NYSE:CHWY) is among the stocks under $50 to buy now. On January 13, Morgan Stanley increased the price target on Chewy, Inc. (NYSE:CHWY) to $51 from $48 and maintained an ‘Overweight’ rating. The firm believes that, for the internet space, this year will be “thematically similar” to the previous year, as the market will favour companies that report significantly positive Return on Invested Capital (ROIC) from GenAI or GPU-enabled technologies. On the other hand, on January 6, Wolfe Research ...
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of PetMed Express, Inc. (NASDAQ: PETS) and Encourages Investors with Substantial Losses to Contact the Firm
Prnewswire· 2025-11-28 20:03
Company Overview - PetMed Express, Inc. is an online pet pharmacy founded in 1996, offering a wide range of medications, supplements, food, and other pet health products [3] Allegations and Stock Performance - On June 10, 2025, PetMed announced a delay in releasing its fourth-quarter and full-year 2025 financial results, leading to a stock drop of $0.47, or 11.22%, closing at $3.72 on June 11, 2025 [4] - On July 1, 2025, PetMed stated it would not file its fiscal-year 2025 Annual Report on time due to an internal review of revenue recognition, resulting in a stock decline of $0.05 per share, or 1.51%, finishing at $3.27 [5] - On November 12, 2025, PetMed reported it could not timely submit its third-quarter 2025 Form 10-Q due to an Audit Committee investigation, causing a significant stock price drop of $0.94 per share, or 32.41%, closing at $1.96 on November 13, 2025 [6] Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving PetMed Express, stemming from allegations of providing misleading business information to the investing public [1]